ABSTRACT The generation of transgenic chickens is of both biomedical and agricultural significance, and recently chicken transgenesis technology has been greatly advanced. However, major issues still exist in the efficient production of transgenic chickens. This study was designed to optimize the production of enhanced green fluorescence protein (EGFP)-transgenic broilers, including egg windowing at the blunt end (air cell) of egg, and the direct transfection of circulating primordial germ cells by microinjection of the Tol2 plasmidliposome complex into the early embryonic dorsal aorta. For egg windowing, we discovered that proper manipulation of the inner shell membrane at the blunt end could improve the rate of producing G 0 transgenic roosters. From 27 G 0 roosters, we successfully collected semen with EGFP-positive sperms from 16 and 19 roosters after direct fluorescence observation and fluorescence-activated cell sorting analyses (13 detected by both methods), respectively. After artificial insemination using the G 0 rooster with the highest number of EGFP fluorescent sperm, one G 1 EGFP transgenic broiler (1/81, 1.23%) was generated. Our results indicate that appropriate egg windowing and screening of potentially transgene-positive roosters can improve the production of germline-transmitted transgenic birds.
INTRODUCTION
Chicken is not only an important farm animal efficient in meat and egg production, but also a useful animal model contributing to basic biomedical research. Transgenic chickens can also produce pharmaceutical proteins for human disease therapy (Lillico et al., 2005) . Recently, several transgenic methods in chickens have been reported, involving the manipulation of different cell types, such as blastodermal cells, primordial germ cells (PGCs), and spermatogonial stem cells. Especially, PGCs, precursors of sperm and eggs, are regarded as the ideal target of cell manipulation C 2018 Poultry Science Association Inc. Received March 29, 2018. Accepted June 29, 2018. 1 Corresponding authors: E-mail: caixiayang@neau.edu.cn (C-XY); lihui@neau.edu.cn (HL) 2 Contributed equally to this work.
to produce germline transgenic birds (van de Lavoir et al., 2006) . To generate germline transgenic chickens, both in vitro and in ovo methods have been developed to manipulate PGCs. The former involves the isolation and culture of circulating PGCs (cPGCs) from the blood vessels of embryos at Hamburger-Hamilton (HH) stages 14-16 (Hamburger and Hamilton, 1951; Macdonald et al., 2012; van de Lavoir et al., 2012) , or gonadal PGCs from embryos at HH stages 28-29 (Park and Han, 2012 ). The cultured PGCs are then transfected in vitro using non-viral vectors, and re-injected into the dorsal aorta of embryos at HH stages 13-16 (Macdonald, et al., 2012; Park and Han, 2012; van de Lavoir, et al., 2012) . However, establishing reliable and stable PGC lines in vitro is a challenging task (Han and Park, 2018) . The latter method involves the direct in ovo microinjection of viral vectors such as lentiviral vectors (McGrew et al., 2004) , or non-viral vectors such as piggyBac transposon vectors (Jordan et al., 2014) , into the sub-germinal cavity of chick embryos at stage X (eggs freshly laid) (Eyal-Giladi and Kochav, 1976; Liu et al., 2013) . The viral vectors are the most commonly used method to manipulate freshly laid eggs at stage X in ovo to produce transgenic birds, but for safety reason, this technique cannot be applied to agricultural production (Park, 2007) .
Although non-viral vectors such as the piggyBac transposon system have also been used to transfect embryos at stage X, an insufficient number of modified PGCs were obtained, and no transgenic offspring was reported (Han et al., 2015) . Moreover, the Tol2 transposon system was employed in the in ovo transfection of chicken PGCs at HH stage 14 embryos, and produced germline transgenic chickens (Tyack et al., 2013) . The Tol2 DNA transposon has been used several times to efficiently integrate transgenes into chicken embryos (Sato et al., 2007) , and avian PGCs in vitro (Macdonald et al., 2012) . The Tol2 transposon system has 3 advantages: (1) large size of transgene inserts (Lambeth et al., 2016) ; (2) transpose efficiently in a variety of cell types in developing embryos (either differentiating somatic cells or germ cells) (Kawakami, 2007) ; and (3) few rearrangements and modifications of the host genome (Balciunas et al., 2006) . Therefore, the application of Tol2 transposon system in chicken transgenesis is reasonable and effective. However, there was only 1 report on the successful production of transgenic chickens using the Tol2 transposon system (Tyack et al., 2013) . It is necessary to better understand the effectiveness of the non-viral vectors, and optimize the manipulation parameters for direct in ovo transfection of PGCs to produce transgenic chickens.
This study was conducted to improve the effectiveness of generating stable germline transgenic birds by non-viral vectors such as the Tol2 transposon system, through optimizing the efficiency of egg windowing, the selection of a suitable embryonic developmental stage, and rapid screening of roosters with higher number of enhanced green fluorescence protein (EGFP)-positive sperms.
MATERIALS AND METHODS

Ethics Statement
Animal work followed the guidelines for the Care and Use of Experimental Animals established by the Ministry of Science and Technology of the People's Republic of China (Approval number: 2006-398) , and was also approved by the Laboratory Animal Management Committee at Northeast Agricultural University, (Harbin, China).
Experimental Animals
Fresh fertilized eggs collected from Arbor Acres Plus (AA+) hens were used to produce G 0 transgenic chickens. The G 0 male (female) birds had access to feed and water ad libitum from hatching to 2 wk of age (from hatching to 4 wk of age), then were feed restricted from 3 to 60 wk of age (from 5 to 60 wk of age) according to the guidelines given in Arbor Acres Plus Broiler Parent Stock Management Handbook (Newbridge, 2014) . G 1 chicks were produced by artificially inseminating wildtype AA+ hens with semen from G 0 roosters.
Egg Windowing
Blunt end (air cell) windowing was performed, based on a previous method with some modifications (Bednarczyk et al., 2000) . Briefly, eggs were placed vertically with the blunt end facing upwards, and after 55-56 h of incubation, embryos reached HH stages 14-15 (Kawabe et al., 2008) . Egg windowing was carefully performed at the blunt end with fine forceps, by simultaneously removing eggshell and the outer shell membrane (approximately 10 mm in diameter), and subsequently peeling off the inner shell membrane (approximately 5 mm in diameter over the embryo) by a plastic pipette tip to expose embryo. Finally, the stripped-off inner shell membrane was recovered into the original location by a plastic pipette tip or gently shaking the eggs ( Figure S1 , Supplementary data). Egg windowing at the sharp end (non-air cell) was carefully performed with fine forceps, by simultaneously removing eggshell, the outer shell membrane and the inner shell membrane. In addition, nothing was added to the egg, such as saline, tyrodes, or penicillin.
Vector Preparation and Microinjection
The Tol2 plasmid system used in this study was kindly provided by Dr. Timothy J. Doran (CSIRO Biosecurity Flagship, Australian Animal Health Laboratory, Geelong, Victoria, Australia). Vectors of pT2-001 and pT2-002 are designed to express EGFP and transposase under the control of pCAGGS promoter (Balciunas et al., 2006) , which contains the cytomegalovirus early enhancer, the first exon and the first intron of chicken beta-actin gene, and the splice acceptor of the rabbit beta-globin (Miyazaki et al., 1989) .
The plasmids of pT-001 and pT-002 were purified by the anion exchange resin used in PureLink plasmid purification kits (Invitrogen) according to the manufacturer's instructions. Based on a method published previously (Tyack et al., 2013) , the purified plasmids (0.6 μg pT2-001 and 1.2 μg pT2-002) were mixed with 45 μL 1× OptiPro SFM (Invitrogen) and incubated at room temperature for 5 min, while 3 μL Lipofectamine 2000 (Invitrogen) was diluted in 45 μL 1× OptiPro SFM and incubated for 5 min. The 2 solutions were then mixed together to form the Tol2 plasmid-liposome complex. Prior to injection, the complex was incubated at room temperature for 20 min.
Embryos at HH stages 14-15 were determined, and then microinjection was performed, all directly under the dissecting microscope and external light. A total of 2 μL plasmid-liposome complex was injected into the dorsal aorta of embryos at HH stages 14-15 using the fine glass capillary injection needles prepared in-house. The injection needles were pulled from Pyrex glass capillaries, with a diameter of 10-20 μm at the tip, and beveled at a 22.5 degree angle. After injection, the egg window was immediately sealed with Parafilm, and the eggs were submitted for incubation at 37.8
• C until hatching ( Figure S1 , Supplementary Data).
Detection of EGFP Fluorescence Signal in Embryos and Gonads
During incubation, the embryos and gonads at various developmental stages were randomly selected, and carefully observed for EGFP signal by direct fluorescence observation (DFO) under the fluorescence microscope (Leica DM IRB, Wetzlar, Germany).
After birth, male G 0 chickens at different ages were also randomly selected, and sacrificed for the detection of testicular fluorescence with GFsP-5 (long wavelength blue) goggles (BLS Ltd., Budapest, Hungary).
Immunohistochemistry to IDENTIFY PGCs
The protocol for immunohistochemical identification of PGCs has been reported previously (Choi et al., 2010) . Briefly, gonads were taken from the embryos at embryonic day (ED) 13, and dissociated using 1× 0.25% trypsin-EDTA (Invitrogen) for 30 min at 37
• C. DMEM containing 20% fetal bovine serum and phosphatebuffered saline (PBS) buffer were used to wash cells 3 times (5 min each time). Cells were mounted onto glass slides, and fixed in 4% paraformaldehyde solution for 30 min at 4
• C. The slides were then blocked with PBS containing 5% bovine serum albumin (BSA, Sigma) for 30 min. After washing 3 times with PBS (5 min each time), the slides were incubated overnight with the primary mouse monoclonal IgM antibody against stagespecific embryonic antigen (SSEA)-1 (catalog numbers: sc-101,462, MC-480, Santa Cruz, CA), which was diluted at 1:100 in 1% BSA and preserved at 4
• C. After washing 3 times with PBS (5 min each time), slides were incubated with the secondary polyclonal goat antimouse IgM+IgG+IgA (H+L) antibody, TRITC conjugate (catalog number: AP501R, Millipore, Beijing, China), which was diluted at 1:1000 in 1% BSA, and preserved for 2 h at room temperature before using, and then washed again 3 times with PBS (5 min each time). Finally, slides were mounted with SlowFade Gold Antifade Reagent with 4 ,6 -diamidino-2-phenylindole (Invitrogen), and visualized under a fluorescence microscope (Nikon, Tokyo, Japan).
Detection of EGFP-Positive Sperms
Semen was collected from individual G 0 roosters using the dorso-abdominal massage technique, and pooled in a 1.5 ml Eppendorf tube (Burrows and Quinn, 1937) . Fresh semen (10 μL) was dropped onto glass slides, and analyzed by the DFO method. The EGFP-positive sperms were observed under a fluorescence microscope (Nikon) at 488 nm with a magnification of ×400. Then, after dilution of 10 μL of the same fresh semen samples in PBS (1:200), 10 μL of the diluted sample was dropped onto a glass slide. Five microscopic fields were randomly selected, and the number of the fluorescent sperms was counted under a bright microscope (Nikon) (magnification at ×400). The total number of sperms in the 5 fields was counted with a handheld cell counter. The ratio of the EGFP-positive sperms in semen was calculated by dividing the number of the EGFP-positive sperms with the total number of sperms in the 5 fields.
In parallel, semen was collected from the G 0 roosters and analyzed for EGFP fluorescence signal by fluorescence-activated cell sorting (FACS) as described previously (van de Lavoir et al., 2012) . The rate of EGFP-positive sperms was analyzed using a FACS equipped with an argon laser (488 nm) (AiraII BD, American). Firstly, 10 μL fresh semen samples were diluted with 1 mL PBS buffer to obtain a suspension. Then, the suspension solution was filtered through the strainer caps of BD Falcon 5 mL polystyrene tubes. Finally, the filtered suspensions were measured in duplicates (10 000 cells per sample) by FACS. The ratio of the EGFP-positive sperms in semen was then calculated by dividing the number of the EGFP-positive sperms with a total of 10 000 cells. The semen samples from wild-type roosters were used as controls.
Detection of EGFP-positive Transgenic Chicken
The G 0 transgenic roosters were used as founders to produce G 1 offsprings. Semen of each rooster was collected to artificially inseminate 10 AA+ hens. Eggs laid were then labeled and incubated. Hatched G 1 chicks were observed for green fluorescence using GFsP-5 goggles.
Detection of transgenic chickens was performed in 4 steps. Firstly, EGFP gene from G 1 transgenic chick was amplified by PCR. Briefly, genomic DNA was extracted from the blood of G 1 EGFP-positive chicks using a General AllGen Kit, and a 719-bp fragment of the EGFP coding sequence was amplified from the forward primers (5 -TACTTGTACAGCTCGTCCATGCCGT-3 ) and reverse primers (5 -ATGGTGAGCAAGAGGG CGAGGAGCTGT-3 ). Polymerase chain reaction (PCR) were carried out in a reaction volume of 10 μL, which included 1× PCR reaction buffer, 200 μM each dNTP, 0.25 μM each primer, 1 μL of genomic DNA (50 ng/μL), and 0.5 U of ExTaq polymerase (TaKaRa). PCR was performed using T-GRADIENT (Biometra, Germany) under the following conditions: initial denaturation at 95
• C for 2 min followed by 35 cycles of 95
• C for 10 s, 59
• C for 30 s, 72
• C for 50 s, and a final extension at 72 • C for 10 min. The pT2-001 plasmid was used as a positive control, and the genomic DNA from a wild-type chicken was used as a negative control.
Secondly, the insertion sites of the transgene in the genome of the G 1 transgenic chick were determined by genome walking. Briefly, 3 specific primers designed to amplify the pT2-001 plasmid left hand end (LHE) were synthesized by a commercial company (Invitrogen, Shanghai, China) (SP1: 5 -GCGGAACTCCATA TAT GGGCTATGA-3 ; SP2: 5 -GCAGCTGCTGATGAAT CACAT ACTTC-3 ; SP3: 5 -AGGACCAATGAACAT GTCTGACC-3 ). The 9 random primers offered in the KX Genome Walking Kit were used for genome walking PCR (ZOMANBIO, Beijing, China) according to the manufacturer's protocol. The third-round PCR products were gel-purified, and then cloned into the pEASYBlunt Zero Cloning Kit (TRANSGEN BIOTECH, Beijing, China). The cloned plasmids were sequenced by a commercial company (Invitrogen, Shanghai, China). Sequencing results were analyzed by BLAST against Assembled Genome Database (http://blast.ncbi.nlm. nih.gov), to reveal the locations of transgene insertion in the chicken genome.
Thirdly, specific primers were designed to amplify the determined transgene regions between the pT2-001 plasmid right hand end (RHE) and the known gene sequences (pT1-001 plasmid forward: 5 -AGACTAAT ACACCTCTTCCCGC-3 and CACNA1C reverse: 5 -C CCACCATTCATCCTCTTG-3 , pT1-001 plasmid forward: 5 -AGACTAATACACCTCTTCCCGC-3 and KCNQ3 Reverse: 5 -GCAACTCCATTCAGAAACTC TC-3 ), to further confirm the insertion location of the pT2-001 plasmid RHE (Text S1, Supplementary Data).
Lastly, the expected whole insertion sequence information (Tol2LHE-pCAGGS-EGFP-Tol2RHE) of the pT2-001 plasmid was verified by amplification of PCR with genomic DNA of G 1 transgenic chicken as templates, and was sequenced by a commercial company (Invitrogen, Shanghai, China). Sequencing results were aligned with the pT2-001 plasmid in the DNAMAN software, to see whether they matched to each other (Text S1, Supplementary Data).
Statistical Analysis
The chi-square test was used to analyze the hatchability data. A value of P < 0.05 was considered to be statistically significant.
RESULTS
Egg Windowing at Blunt End to Improve Hatchability
We aimed to improve the hatchability of eggs at HH Stages 14-15 manipulated by different methods of egg windowing. The results showed that hatchability of egg windowing at the blunt end was obviously higher than the sharp end (70.0% vs. 53.3%, P < 0.05), even though egg windowing at the blunt end caused obviously larger diameters of eggshell (10 mm) and outer shell membrane (10 mm), than those of eggshell (5 mm) and outer shell membrane (5 mm) after manipulation at the sharp end (Table 1) . Moreover, for egg windowing at the blunt end and sharp end, no difference existed for the diameter of inner shell membrane (5 mm) ( Table 1) .
In addition, we found that when egg windowing at the blunt end, the manipulation of stripping the inner shell membrane and recovering the membrane into the original location led to a smaller window on the inner shell membrane (5 mm in diameter) (supplementary data: Figure S1 ). This manipulation had a significantly higher hatchability than the direct removal of the inner shell membrane (20 mm in diameter) (70.0% VS. 6.7%, P < 0.05) ( Table 1) . Of note, diameters of eggshell (10 mm) and outer shell membrane (10 mm) were not different, either (Table 1) .
Generation of G 0 Transgenic Chickens
All eggs were arranged and incubated to ensure that chick embryos developed to HH stages 14-15 for microinjection (supplementary data: Table S1 ). The Tol2 transposon plasmid-liposome complex was injected into the dorsal aorta of chick embryos at HH stages 14-15 by egg windowing at the blunt end of eggs (supplementary data: Figure S1 ). A total of 257 embryos were successfully injected in 4 batches, and during incubation, 59 embryos were randomly sampled and submitted for EGFP detection. For the remaining 198 embryos, 136 chicks were successfully hatched, with hatching rates ranging from 61.4%-81.0% (average 68.7%) (supplementary data: Table S2 ).
We first observed EGFP signals in the blood vessels ( Figure 1A ), heart ( Figure 1B ), brain ( Figure 1C) , and mesoderm ( Figure 1D ) of early embryos (8/8) at 69-70 h of incubation, by DFO under the fluorescence microscope, implying that different type of cells were transfected by the Tol2 plasmid-liposome complex. The EGFP expression is mosaic in the G 0 generation, as expected. Next, to determine whether cPGCs are transfected in ovo by the Tol2 plasmid-liposome complex, we checked the fluorescence of dissected gonads from various embryonic development (ED) stages, by DFO under the fluorescence microscope. At ED 4-13, we observed EGFP signals in 73.3% (22/30) of the gonads ( Figure 1E , Table 2 ).
After birth, male G 0 chickens at different ages were randomly selected and sacrificed, for the purpose of testing testicular fluorescence with GFsP-5 goggles. We found that the testicles of 15/26 immature (Table 2, Figure 1F ), 4/8 sexually mature roosters were EGFPpositive by the DFO analysis, respectively (Table 2 , Figures 1F-1H, 1I 1 and 1I 2 ) . Semen was collected from 27 sexually mature roosters, in which 16 and 19 roosters were transgenic as detected by the DFO and FACS analyses, respectively (13 birds detected by both methods) (Table 3) .
Moreover, immunostaining showed that cells isolated from the EGFP-positive gonads of one embryo at ED 13 were SSEA-1 positive, confirming that the EGFPpositive cells are PGCs (Figures 2A-2D ).
Screening EGFP-positive Sperms from G 0 Transgenic Roosters
EGFP-positive sperms in the semen produced from G 0 transgenic roosters were rapidly and accurately screened by the DFO and FACS analyses. Four batches of DFO analyses showed that the highest percentages of EGFP-positive sperms were 0.18% from rooster no. 1-7 in the first batch, 0.12% from no. 2-4 in the second batch, 0.13% from no. 3-7 in the third batch and 0.32% from no.4-2 in the fourth batch (Table 3, Figure 3A) . At the same time, FACS analysis on the same set of semen samples showed that the highest percentages within each batch were 6.6% from rooster no. 1-7, 1.3% from rooster no. 2-4, 1.6% from rooster no. 3-7 and 9.6% from rooster no.4-2 (Table 3, Figure 3B ). Both DFO and FACS analyses gave the same ranking order of G 0 roosters containing the highest percentages of EGFP-positive sperms, suggesting that these 2 methods were valid, and could be used as effective methods for rapidly screening G 0 transgenic roosters.
Generation and Validation of G 1 Transgenic Chicks
Four roosters (no. 1-7, no. 2-4, no. 3-8 and no.4-2) with the highest numbers of EGFP-positive sperms within each batch were selected as founders for producing G 1 transgenic chicks. The founder roosters were each mated with 10 AA+ hens by artificial insemination. Of 306, 365 and 301 chicks generated from roosters no. 1-7, no. 2-4 and no. 3-8, respectively, none was EGFP-positive as detected directly by GFsP-5 goggles. Rooster no. 4-2, producing semen containing the highest percentage of EGFP-positive sperms in all G 0 roosters, produced one EGFP-positive chick out of 81 G 1 chicks hatched, giving a germline transmission rate of 1.23%. Strong EGFP signals were detected in the beak, eyes, legs, and claws of the female chick at 2 wk of age using GFsP-5 goggles ( Figures 4A and 4B) . Indeed, even under natural light, lighter yellow color on these body parts were visible, when compared to the control chicks. To validate if this chick were truely transgenic, we performed genomic PCR, and amplified a 719 bp EGFP-specific fragment from the genomic DNA extracted from the blood of this chick. The PCR product size was identical to that of the positive control (EGFP fragments of pT2-001 plasmids). No EGFPspecific fragments were amplified from the negative control (wild-type chicken genomic DNA) or water ( Figure 4C) .
We further determined the genomic integration sites of the transgene by genome walking. We cloned and sequenced flanking sequences of the transgene Tol2-EGFP. After BLAST analysis, 2 genomic integration sites were revealed. One integration site located in the fifth intron of CACNA1C gene on chicken chromosome 1 (genome coordinate: 294 899) ( Figure 5A ), and the other one, in the first intron of KCNQ3 gene on chicken chromosome 2 (genome coordinate: 101 539) ( Figure 5B ), respectively. An 8-bp duplication of genomic DNA on either side of the transposon was found in CACNA1C (ATAATGTC) and KCNQ3 (AGTCTACC). The whole length of the inserted Tol2 transposon element was 4090 bp long (encompassing Tol2LHE-pCAGGS-EGFP-Tol2RHE of the plasmid) at each integration site, as identified by genome sequencing (supplementary data: Text S1).
DISCUSSION
Many factors affect the efficiency of transgenic chicken production, egg windowing is one of the major concerns, which is associated with the hatch rate and the subsequent production of G 0 transgenic chickens (Andacht et al., 2004) . For transgenic manipulations performed around the HH 14 stage, previously, after egg windowing at the sharp end (also called pointed end), performed by simultaneously removing the eggshell, and both the outer and inner shell membranes of chick eggs, a hatchability of 40.0% was achieved (Tyack et al., 2013) . In the present study, we improved the hatch rate to 68.7% (supplementary data: Table S2 ), by simultaneously removing the eggshell and the outer shell membrane, but replacing the stripped-off inner shell membrane back into the original location of eggs. In the current study, we found also that hatchability of egg windowing at the blunt end was also obviously higher than manipulation at the sharp end (70.0% VS. 53.3%, P < 0.05) ( Table 1) . One possible explanation for our higher hatchability is that there is a unique natural structure called "air cell" inside each egg, where a space is formed between adherent outer shell membrane and detached inner shell membrane. Our manipulation to recover the stripped-off inner shell membrane into its original location at the blunt end is less detrimental than the operation on windowing at the sharp end (Bednarczyk et al., 2000) . Furthermore, we observed that the removal of inner shell membrane (20 mm) at the blunt end significantly influenced the hatchability (6.7%, P < 0.05) ( Table 1) . One possible explanation for the increased survival rate is that replacing back the inner shell membrane might help reduce dehydration, which, as a major factor in embryonic death, could cause a reduced hatch rate (Bednarczyk et al., 2000) .
Thus, egg windowing at the blunt end is a better method for embryo microinjection, and the inner shell membrane is vital to chick hatchability.
Another crucial step in avian transgenesis is the selection of a suitable embryonic developmental stage for manipulation. Previous studies showed that about 80% of total PGCs are found in the capillaries of the yolk sac at HH stage 14, which then migrate into the vascular system, settle into future gonads, and finally differentiate into functional sperm (Nakamura et al., 1991; Tajima et al., 1999) . Therefore, direct microinjection in ovo into the stage HH 14-15 embryos was mainly used to transfect cPGCs by non-viral vectors (Watanabe et al., 1994) , or infect cPGCs by viral vectors (Kawabe et al., 2008) . However, less description in the literature can be found on how it can be guaranteed that every chick embryo during the microinjection is maintained at the same developmental stage in order to transfect cPGCs efficiently. In the present study, all eggs were set for incubation at different time points to ensure every chick embryos were developmentally at HH stages 14-15 for efficient microinjection (supplementary material: Table S1 ). As a result, many embryos, gonads, testicles, and sperms were detected to be EGFPpositive during the process of generating G 0 transgenic chickens (Figure 1 ; Tables 2 and 3), especially the rate of G 0 transgenic roosters by DFO (16/27, 59 .3%), which was higher than that reported in a recently published review (Bednarczyk et al., 2018) . Therefore, HH stages 14-15 are ideal for microinjection, and practitioners should design accordingly the right incubation program to make sure all embryos are at the right stage (i.e., HH stages 14-15).
Rapid and accurate screening of transgenic roosters is also essential for producing efficiently germlinetransmitted transgenic chickens. Several methods, including immunocytochemistry (Heo et al., 2011) , FACS analysis (van de Lavoir et al., 2012) , and qPCR (Tyack et al., 2013) , have been used to detect EGFP-positive semen in roosters. Although many methods were reported previously, we attempted a simpler method, to find roosters producing EGFP-positive sperms. PGCs are precursors of sperm, and EGFP-positive cPGCs should differentiate into EGFP-positive sperms. Direct observation of semen samples collected from G 0 roosters under the fluorescence microscope helped us to select a rooster with the largest number of EGFP-positive sperms by both DFO and FACS analyses (rank orders of roosters were the same for both methods). This method is intuitive, rapid, and efficient, and can be used for quick and accurate screening of G 0 transgenic roosters. Previous attempts to detect GFP-positive chicken sperm by direct fluorescence microscopy were unsuccessful, possibly because of the low GFP expression under the control of the cytomegalovirus promoter (Heo et al., 2011) . EGFP-positive sperms were readily observable in our work, possibly due to the higher activity of the pCAGGS promoter in spermatozoa.
As for the integration sites of the Tol2 transposon plasmid in the transgenic chicken, different findings were reported. Previously, the Tol2 transposon were found to be integrated into 4 different regions in the transgenic offsprings, including PTPRH and family CR1 genes on chicken chromosomes Z and 2, and 2 other unannotated genes on chicken chromosomes 20 and 3, respectively (Lambeth et al., 2016) . In this study, integration sites of Tol2-EGFP transposon sequences in the single G 1 transgenic chick located in the intronic regions of CACNA1C and KNCQ3 genes on chromosomes 1 and 2, respectively. Conceivably, Tol2 transposon sequences could randomly be inserted into different chromosomal regions of cPGCs at the early embryonic development stage, and many transgenic sperms with different insertion sites will be formed. Ultimately, for transgenic offsprings produced, their genomes will also have randomly integrated Tol2 transposon sequences. In addition, EGFP-negative offsprings, possibly caused by the epigenetic silencing of transposable elements (Nichols et al., 2016) , should also be screened for the presence of the integration sites of the Tol2 transposon. To better understand the molecular mechanism of integration sites of the Tol2 transposon between the EGFP-positive and -negative offsprings, further investigation is still warranted.
CONCLUSION
Microinjection of the Tol2 transposon plasmid system at the HH stages 14-15 of chick embryos was effective for producing transgenic chickens as reported previously. Egg windowing at the blunt end (air cell) and minimization of the injury of its inner shell membrane contributed to improving the hatchability. Screening roosters with EGFP-positive sperms using DFO and FACS could elevate the productivity of making transgenic chickens. Taken together, optimization of the chicken transgenesis procedure can help with the efficient production of transgenic chickens.
SUPPLEMENTARY DATA
Supplementary data are available at Poultry Science online. Table S1 . Methods of obtaining the HH stages 14-15 embryos that were incubated for 55-56 h. 
